Results 221 to 230 of about 2,044,874 (243)

Microbial Signals in Cancer: Dissecting Host–Microbiota–Tumor Interactions and Potential Therapeutic Strategy

open access: yesMedComm, Volume 7, Issue 9, September 2026.
Microbial signals from gut and tumor‐resident bacteria, fungi, viruses, and bacteriophages reshape immune and metabolic networks within the tumor microenvironment, thereby influencing cancer progression, treatment response. Therapeutic modulations, including dietary interventions, probiotics, antibiotics, fecal microbiota transplantation, engineered ...
Juan Lu   +8 more
wiley   +1 more source

Optimizing Research Operations and Resource Utilization in ALS Care: Insights From the Tofersen Antisense Oligonucleotide Expanded Access Protocol

open access: yesMuscle &Nerve, Volume 74, Issue 3, Page 692-697, September 2026.
ABSTRACT Introduction/Aims Tofersen is a gene‐targeted therapy for individuals with superoxide dismutase 1 (SOD1) (+) amyotrophic lateral sclerosis (ALS). Prior to U.S. Food and Drug Administration (FDA) approval, tofersen was made available through expanded access protocol.
Alison Wheeler   +30 more
wiley   +1 more source

Independent Risk Factors for Postoperative Intestinal Obstruction and Clinical Outcomes in Simultaneous Pancreas‐Kidney Transplantation Recipients

open access: yesOrgan Medicine, Volume 3, Issue 3, Page 157-170, September 2026.
Intestinal obstruction (IO) is an important but underexplored complication following simultaneous pancreas‐kidney transplantation (SPKT) and is associated with considerable morbidity and both clinical and economic burdens. In this single‐center cohort study, perioperative parameters, including demographic characteristics, surgical variables, and ...
Rongxin Chen   +7 more
wiley   +1 more source

Protocol of a single‐arm open‐label pilot study of extended rTMS therapy for treatment‐resistant depression (ExTMS study)

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Background Repetitive transcranial magnetic stimulation (rTMS) for treatment‐resistant depression (TRD) has been covered by the Japanese public health insurance system. Standard public insurance‐covered treatment is limited to a 30‐session course delivered over 8 weeks.
Shun Takahashi   +4 more
wiley   +1 more source

CD3+/CD56+ NKT-like Cells Show Imbalanced Control Immediately after Exercise in Delayed-Onset Muscle Soreness [PDF]

open access: yesInternational Journal of Molecular Sciences, 2022
The purpose of the study was to carry out an immunophenotypical characterization with a special focus on natural killer cells of junior swimmers from the Hungarian National Swim Team before and after an intensive acute exercise.
Nora Sydo
exaly   +2 more sources

The Effects of Static and Ballistic Stretching on Delayed Onset Muscle Soreness and Creatine Kinase

Research Quarterly for Exercise and Sport, 1993
Joseph Houmard   +2 more
exaly  

Home - About - Disclaimer - Privacy